News & Articles

Results per page

Selected Filters:

Industry News

MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology

Collaboration aims to develop novel antibody-based therapies targeting tumor-associated peptides derived from intracellular proteins

24 Aug 2015

Product News

Key US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders

5 Dec 2008

Product News

MorphoSys Announces Publication of First MOR103 Data

1 Sept 2008

Product News

Boehringer Ingelheim Gains Access to Additional MorphoSys Technology

8 Jul 2008

Product News

AbD Serotec Receives Large Research Antibody Order from Proteomics Specialist Proteomika

7 Mar 2008

Product News

MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies

22 Feb 2008

Product News

MorphoSys Announces Development of New Antibody Platform Technology

21 Nov 2007

Product News

MorphoSys Announces Clinical Milestone in Antibody Program

17 Sept 2007

Product News

MorphoSys Presents New RapMAT™ Antibody Technology

13 Dec 2006

Product News

MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD® in Cancer Research

7 Jun 2006

Product News

Roche Plans Clinical Trial with MorphoSys-Generated Alzheimer Antibody

28 Jan 2006

Product News

MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies

12 Jan 2006

News & Articles

Articles Filter

Search

Selected Filters:

MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology

Key US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders

MorphoSys Announces Publication of First MOR103 Data

Boehringer Ingelheim Gains Access to Additional MorphoSys Technology

AbD Serotec Receives Large Research Antibody Order from Proteomics Specialist Proteomika

MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies

MorphoSys Announces Development of New Antibody Platform Technology

MorphoSys Announces Clinical Milestone in Antibody Program

MorphoSys Presents New RapMAT™ Antibody Technology

MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD® in Cancer Research

Roche Plans Clinical Trial with MorphoSys-Generated Alzheimer Antibody

MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology

Key US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders

MorphoSys Announces Publication of First MOR103 Data

Boehringer Ingelheim Gains Access to Additional MorphoSys Technology

AbD Serotec Receives Large Research Antibody Order from Proteomics Specialist Proteomika

MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies

MorphoSys Announces Development of New Antibody Platform Technology

MorphoSys Announces Clinical Milestone in Antibody Program

MorphoSys Presents New RapMAT™ Antibody Technology

MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD&#174; in Cancer Research

Roche Plans Clinical Trial with MorphoSys-Generated Alzheimer Antibody

MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies

Articles Filter

MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD® in Cancer Research